ResearcherOkayama University HospitalNo recent work listed

Hiroki Sato

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3945-9313; OpenAlex author ID A5023580097. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2022: 1 paper

Papers 1

Feasibility of local therapy for recurrent pancreatic cancer. Co-author DOI 10.1016/j.pan.2022.05.004 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kazuya Yasui · 1 shared paper, 2022 · strength 0.15
- Paper Feasibility of local therapy for recurrent pancreatic cancer. DOI 10.1016/j.pan.2022.05.004 ↗
Kazuhiro Yoshida · 1 shared paper, 2022 · strength 0.15
- Paper Feasibility of local therapy for recurrent pancreatic cancer. DOI 10.1016/j.pan.2022.05.004 ↗
Yuzo Umeda · 1 shared paper, 2022 · strength 0.15
- Paper Feasibility of local therapy for recurrent pancreatic cancer. DOI 10.1016/j.pan.2022.05.004 ↗
Kosei Takagi · 1 shared paper, 2022 · strength 0.15
- Paper Feasibility of local therapy for recurrent pancreatic cancer. DOI 10.1016/j.pan.2022.05.004 ↗
Ryuichi Yoshida · 1 shared paper, 2022 · strength 0.15
- Paper Feasibility of local therapy for recurrent pancreatic cancer. DOI 10.1016/j.pan.2022.05.004 ↗
Toshiyoshi Fujiwara · 1 shared paper, 2022 · strength 0.15
- Paper Feasibility of local therapy for recurrent pancreatic cancer. DOI 10.1016/j.pan.2022.05.004 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.